Summary

Peripheral Arterial Disease Treatment Market – Scope of Report
TMR’s report on the global peripheral arterial disease treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peripheral arterial disease treatment market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral arterial disease treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peripheral arterial disease treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral arterial disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral arterial disease treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral arterial disease treatment market.

The report delves into the competitive landscape of the global peripheral arterial disease treatment market. Key players operating in the global peripheral arterial disease treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral arterial disease treatment market profiled in this report.

Key Questions Answered in Global peripheral arterial disease treatment market Report
• What is the sales/revenue generated by peripheral arterial disease treatment across all regions during the forecast period?
• What are the opportunities in the global peripheral arterial disease treatment market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Peripheral Arterial Disease Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global peripheral arterial disease treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peripheral arterial disease treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral arterial disease treatment market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Peripheral Arterial Disease Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Regulatory Landscape across Key Regions / Countries
5.2. Market Trends
5.3. PORTER’s Five Forces Analysis
5.4. PESTEL Analysis
5.5. Key Purchase Metrics for End-users
5.6. Brand and Pricing Analysis
5.7. Treatment Algorithm
5.8. Key Industry Events
6. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Drug Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Drug Type, 2020-2035
6.3.1. Antiplatelet Drugs
6.3.2. Cholesterol-Lowering Drugs (Statins)
6.3.3. Anti-hypertensive Drugs
6.3.4. Blood Pressure Medications
6.3.5. Vasodilators
6.3.6. Others
6.4. Market Attractiveness By Drug Type
7. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Route of Administration, 2020-2035
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Attractiveness By Route of Administration
8. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2020-2035
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Peripheral Arterial Disease Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Drug Type, 2020-2035
10.2.1. Antiplatelet Drugs
10.2.2. Cholesterol-Lowering Drugs (Statins)
10.2.3. Anti-hypertensive Drugs
10.2.4. Blood Pressure Medications
10.2.5. Vasodilators
10.2.6. Others
10.3. Market Value Forecast By Route of Administration, 2020-2035
10.3.1. Oral
10.3.2. Parenteral
10.4. Market Value Forecast By Distribution Channel, 2020-2035
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Drug Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 01: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 02: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 03: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Antiplatelet Drugs, 2020-2035

Figure 04: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Cholesterol-Lowering Drugs (Statins), 2020-2035

Figure 05: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Anti-hypertensive Drugs, 2020-2035

Figure 06: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Blood Pressure Medications, 2020-2035

Figure 07: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Vasodilators, 2020-2035

Figure 08: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035

Figure 09: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 10: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 11: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Oral, 2020-2035

Figure 12: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035

Figure 13: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 14: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 15: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035

Figure 16: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035

Figure 17: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035

Figure 18: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Region, 2024 and 2035

Figure 19: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Region, 2025-2035

Figure 20: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 21: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country, 2024 and 2035

Figure 22: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country, 2025-2035

Figure 23: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 24: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 25: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 26: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 27: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 28: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 29: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 30: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 31: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 32: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 33: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 34: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 35: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 36: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 37: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 38: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 39: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035

Figure 40: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035

Figure 41: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 42: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 43: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 44: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 45: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 46: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 47: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 48: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 49: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 50: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 51: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 52: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 53: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 54: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 55: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 56: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 57: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 58: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 59: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 60: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035

Figure 61: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 62: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 63: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 64: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035